AnaptysBio, Inc. (ANAB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 513.32M |
| Enterprise value | 140.23M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 30.10 |
| Price/book (mrq) | 5.83 |
| Enterprise value/revenue | 8.17 |
| Enterprise value/EBITDA | -0.98 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.29 |
| 52-week change 3 | -8.54% |
| S&P500 52-week change 3 | 25.01% |
| 52-week high 3 | 27.50 |
| 52-week low 3 | 13.36 |
| 50-day moving average 3 | 23.10 |
| 200-day moving average 3 | 20.07 |
Share statistics
| Avg vol (3-month) 3 | 322.38k |
| Avg vol (10-day) 3 | 325.91k |
| Shares outstanding 5 | 26.76M |
| Implied shares outstanding 6 | 26.76M |
| Float 8 | 14.73M |
| % held by insiders 1 | 0.40% |
| % held by institutions 1 | 113.52% |
| Shares short (28 Mar 2024) 4 | 4.3M |
| Short ratio (28 Mar 2024) 4 | 11.43 |
| Short % of float (28 Mar 2024) 4 | 23.57% |
| Short % of shares outstanding (28 Mar 2024) 4 | 16.08% |
| Shares short (prior month 29 Feb 2024) 4 | 4.2M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -386.41% |
Management effectiveness
| Return on assets (ttm) | -18.47% |
| Return on equity (ttm) | -93.44% |
Income statement
| Revenue (ttm) | 17.16M |
| Revenue per share (ttm) | 0.64 |
| Quarterly revenue growth (yoy) | 32.30% |
| Gross profit (ttm) | N/A |
| EBITDA | -156.42M |
| Net income avi to common (ttm) | -163.62M |
| Diluted EPS (ttm) | -6.08 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 390.9M |
| Total cash per share (mrq) | 14.61 |
| Total debt (mrq) | 328.62M |
| Total debt/equity (mrq) | 373.00% |
| Current ratio (mrq) | 10.87 |
| Book value per share (mrq) | 3.31 |
Cash flow statement
| Operating cash flow (ttm) | -120.8M |
| Levered free cash flow (ttm) | -73.42M |
© 2024 Yahoo. All rights reserved.